Print This Page Email This Page Share on LinkedIn Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Pharmaceutical ingredients CPhI: Cambrex to Expand High Potency API and Controlled Substances BusinessesPolyOne and Olin Lift Caustic Soda Force MajeureUnion Asks PotashCorp to Resume TalksISP Among First to Obtain Pharmacopeia SealEFCG Welcomes Action on APIs Related Stories Pfizer Seeks to Reduce Solvent UseShell Beefs Up Position in Next Generation BiofuelGenencor and Goodyear to Spend More than $50 Million Codeveloping Bio-isoprene ProcessKlosk Appointed President and CEO of CambrexMonsanto Seeks Buyer for Controversial Milk-Boosting Drug

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

July 1, 2008

Lonza Secures Stem Cell Drug Supply Deal, Will Build Plant at Walkersville, MD

Alex Scott

Contract fine chemicals firm Lonza (Basel, Switzerland) says it has secured a deal with biotech firm Osiris Therapeutics (Columbia, MD) to manufacture what could be the world’s first stem cell drug. Lonza will build a new manufacturing facility at its...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers